GORDON, K.; PAPP, K.; GOODERHAM, M.; MORITA, A.; FOLEY, P.; THA?I, D.; KUNDU, S.; KISA, R.; WEI, L.; BANERGEE, S. BMS-986165, an Oral, Selective Tyrosine Kinase 2 (TYK2) Inhibitor: Evaluation of Changes in Laboratory Parameters in Response to Treatment in a Phase 2 Trial in Psoriasis Patients. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 5, p. s28, 2020. DOI: 10.25251/skin.4.supp.28. Disponível em: https://www.jofskin.org/index.php/skin/article/view/977. Acesso em: 24 jan. 2022.